Company logo

DMTK - DermTech, Inc.

NASDAQ -> Healthcare -> Diagnostics & Research
La Jolla, United States
Type: Equity

DMTK price evolution
DMTK
(in millions $) 30 Sep 2023 30 Jun 2023 31 Mar 2023 31 Jan 2023
Current assets
Cash $40.7 $46.26 $51.94 $81.25
Short term investments $30.97 $43.41 $56.34 $48.41
Net receivables $3.6 $3.87 $3.69 $4.17
Inventory $1.2 $1.35 $1.57 $1.76
Total current assets $75.93 $93.74 $112.39 $136.04
Long term investments
Property, plant & equipment $58.5 $59.87 $61.06 $62.38
Goodwill & intangible assets
Total noncurrent assets $61.97 $63.33 $64.73 $66.04
Total investments $30.97 $43.41 $56.34 $48.41
Total assets $137.9 $157.07 $177.12 $202.07
Current liabilities
Accounts payable $1.7 $2.32 $1.68 $2.42
Deferred revenue $0.24 $0.29 $0.24 $0.11
Short long term debt $2.98 $2.31 $1.85 $1.75
Total current liabilities $12.64 $16.01 $16.14 $15.64
Long term debt $52.2 $52.98 $53.73 $54.08
Total noncurrent liabilities $52.2 $52.98 $53.74 $54.09
Total debt $55.17 $55.29 $55.58 $55.83
Total liabilities $64.83 $69 $69.88 $69.72
Shareholders' equity
Retained earnings -$404.84 -$385.68 -$354.32 -$323.05
Other shareholder equity $0.13 -$0.1 -$0.29 -$0.77
Total shareholder equity $73.06 $88.08 $107.24 $132.35
(in millions $) 31 Jan 2023 31 Dec 2021 31 Dec 2020 31 Dec 2019
Current assets
Cash $81.25 $179.91 $24.25 $15.37
Short term investments $48.41 $48.45 $39.53
Net receivables $4.17 $3.85 $1.48 $0.68
Inventory $1.76 $0.48 $0.1 $0.04
Total current assets $136.04 $232.82 $66.88 $17.15
Long term investments
Property, plant & equipment $62.38 $12.29 $2.73 $0.98
Goodwill & intangible assets
Total noncurrent assets $66.04 $15.48 $2.9 $1.06
Total investments $48.41 $48.45 $39.53
Total assets $202.07 $248.31 $69.78 $18.21
Current liabilities
Accounts payable $2.42 $2.88 $1.57 $1.61
Deferred revenue $0.11 $1.38 $1.54 $1.39
Short long term debt $1.75 $1.57 $0.11
Total current liabilities $15.64 $12.18 $5.42 $5.72
Long term debt $54.08 $6.28 $0.23
Total noncurrent liabilities $54.09 $6.43 $0.86 $5.03
Total debt $55.83 $7.86 $0.34
Total liabilities $69.72 $18.61 $6.29 $5.72
Shareholders' equity
Retained earnings -$323.05 -$206.36 -$126.36 -$91.11
Other shareholder equity -$0.77 -$0.12 -$0
Total shareholder equity $132.35 $229.7 $63.49 $12.49
(in millions $) 30 Sep 2023 30 Jun 2023 31 Mar 2023 31 Dec 2022
Revenue
Total revenue $3.92 $3.98 $3.48 $2.99
Cost of revenue $3.74 $3.97 $3.82 $3.35
Gross Profit $0.17 $0.01 -$0.34 -$0.36
Operating activities
Research & development $3.6 $3.89 $4.41 $5.1
Selling, general & administrative $16.39 $28.25 $27.29 $23.43
Total operating expenses $19.98 $32.14 $31.7 $28.52
Operating income -$19.81 -$32.13 -$32.05 -$28.88
Income from continuing operations
EBIT -$19.16 -$31.36 -$31.27 -$28.22
Income tax expense
Interest expense
Net income
Net income -$19.16 -$31.36 -$31.27 -$28.22
Income (for common shares) -$19.16 -$31.36 -$31.27 -$28.22
(in millions $) 31 Dec 2022 31 Jan 2022 31 Dec 2020 31 Dec 2019
Revenue
Total revenue $14.52 $5.88 $3.36
Cost of revenue $13.87 $5.98 $3.3
Gross Profit $0.65 -$0.1 $0.06
Operating activities
Research & development $24.05 $5.29 $2.5
Selling, general & administrative $94.76 $29.9 $15.17
Total operating expenses $118.81 $35.19 $17.66
Operating income -$118.17 -$35.29 -$17.61
Income from continuing operations
EBIT -$116.68 -$35.29 -$17.03
Income tax expense
Interest expense -$0.04 $2.66
Net income
Net income -$116.68 -$35.25 -$19.69
Income (for common shares) -$116.68 -$35.25 -$19.69
(in millions $) 30 Sep 2023 30 Jun 2023 31 Mar 2023 31 Dec 2022
Net income -$19.16 -$31.36 -$31.27 -$28.22
Operating activities
Depreciation $1.35 $1.48 $1.67 $1.49
Business acquisitions & disposals
Stock-based compensation $3.16 $7.51 $4.74 $5.27
Total cash flows from operations -$19.04 -$23.2 -$22.03 -$21.23
Investing activities
Capital expenditures -$0.05 -$0.26 -$0.76 -$1.93
Investments $12.81 $13.32 -$7.44 $5.47
Total cash flows from investing $12.76 $13.06 -$8.19 $3.54
Financing activities
Dividends paid
Sale and purchase of stock $0.76 $4.5 $0.94
Net borrowings -$0.03 -$0.03 -$0.02 -$0.03
Total cash flows from financing $0.73 $4.46 $0.92 -$0.03
Effect of exchange rate
Change in cash and equivalents -$5.56 -$5.68 -$29.31 -$17.72
(in millions $) 31 Dec 2022 31 Dec 2021 31 Dec 2020 31 Dec 2019
Net income -$116.68 -$78.33 -$35.25 -$19.69
Operating activities
Depreciation $4.46 $2.3 $0.49 $0.09
Business acquisitions & disposals
Stock-based compensation $18.93 $13.28 $4.97 $1.3
Total cash flows from operations -$95.26 -$62.11 -$28.68 -$17.79
Investing activities
Capital expenditures -$3.31 -$2.72 -$1.83 -$0.21
Investments -$1.01 -$9.79 -$39.51
Total cash flows from investing -$4.32 -$12.51 -$41.34 -$0.21
Financing activities
Dividends paid
Sale and purchase of stock $1.05 $230.45 $44.31 $20.74
Net borrowings -$0.14 -$0.17 -$0.01 $2.08
Total cash flows from financing $0.92 $230.28 $78.9 $28.62
Effect of exchange rate
Change in cash and equivalents -$98.66 $155.66 $8.87 $10.62
Fundamentals
Market cap N/A
Enterprise value N/A
Shares outstanding N/A
Revenue $14.37M
EBITDA -$104.03M
EBIT -$110.02M
Net Income -$110.02M
Revenue Q/Q 9.57%
Revenue Y/Y N/A
P/E ratio N/A
EV/Sales N/A
EV/EBITDA N/A
EV/EBIT N/A
P/S ratio N/A
P/B ratio N/A
Book/Share N/A
Cash/Share N/A
EPS N/A
ROA -65.28%
ROE -109.82%
Debt/Equity 0.53
Net debt/EBITDA -0.23
Current ratio 6.01
Quick ratio 5.91